The story
Hernia repair is one of the most common surgeries in America — about a million per year. In most cases, surgeons use a synthetic mesh to patch the hernia, rather than stitching the tissue directly. It was supposed to reduce recovery time and prevent the hernia from coming back.
For thousands of patients, it did the opposite. The mesh devices — particularly those made by C.R. Bard and its subsidiary Davol — began failing inside patients' bodies.
The mesh eroded through tissue, migrated from its original position, caused severe chronic infections, and created adhesions that fused organs together. Patients who went in for a routine 45-minute surgery found themselves in years-long cycles of follow-up surgeries, antibiotic treatments, and debilitating pain. The lawsuits allege that manufacturers rushed products to market without adequate testing, used materials that the body rejects, and failed to warn surgeons and patients about known failure rates.